PRODUCTS SOLD ON POWERPEPTIDES.CO.UK ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE
Our GLP-1 Weight Loss Pathway is designed specifically for individuals looking to shed pounds effectively, safely, and sustainably
consumers should review OpenLoop's telehealth consent at openloophealth.com/telehealth-consent and ask FeelGood support specific data privacy questions before enrollment FDA compounded GLP-1 adverse events: The FDA received 1,150+ adverse event reports related to compounded semaglutide/tirzepatide as of July 2025, including dosing errors with vial-based injectables
Our clinical team is dedicated to providing friendly, professional, and entirely personalized care to help you discover the treatment pathway that fits perfectly into your life
Testing may include: Dilated eye exam Optic nerve evaluation Retinal imaging OCT scan of the optic nerve and macula Visual field testing Blood pressure and medical history review Discussion of diabetes, sleep apnea, cholesterol, and cardiovascular risk factors Your eye doctor may also coordinate care with your primary care doctor, endocrinologist, or prescribing provider if there are concerns
